凯普生物(300639.SZ)发布前三季度业绩，归母净亏损1.28亿元

Core Viewpoint - Capbio reported a significant decline in revenue and an increase in net loss for the first three quarters of 2025, indicating financial challenges for the company [1] Financial Performance - The company's operating revenue for the first three quarters was 486 million yuan, a year-on-year decrease of 20.38% [1] - The net loss attributable to shareholders was 128 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 135 million yuan [1] - The basic loss per share was 0.1996 yuan [1]